Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Diffusion of new technology and payment policies: coronary stents.

Shih C, Berliner E.

Health Aff (Millwood). 2008 Nov-Dec;27(6):1566-76. doi: 10.1377/hlthaff.27.6.1566.

2.

Policy implications of the diffusion and control of medical technology.

Banta HD, Burns AK, Behney CJ.

Ann Am Acad Pol Soc Sci. 1983 Jul;(468):165-81.

PMID:
10299096
3.

The diffusion of medical technology, local conditions, and technology re-invention: a comparative case study on coronary stenting.

Hashimoto H, Noguchi H, Heidenreich P, Saynina O, Moreland A, Miyazaki S, Ikeda S, Kaneko Y, Ikegami N.

Health Policy. 2006 Dec;79(2-3):221-30. Epub 2006 Feb 13.

PMID:
16473435
4.

Diffusion of medical technology: the role of financing.

Cappellaro G, Ghislandi S, Anessi-Pessina E.

Health Policy. 2011 Apr;100(1):51-9. doi: 10.1016/j.healthpol.2010.10.004. Epub 2010 Nov 4.

PMID:
21055840
5.

Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program.

Ryan J, Linde-Zwirble W, Engelhart L, Cooper L, Cohen DJ.

Circulation. 2009 Feb 24;119(7):952-61. doi: 10.1161/CIRCULATIONAHA.108.781138. Epub 2009 Feb 9.

6.
7.

The adoption and diffusion of CT and MRI in the United States. A comparative analysis.

Hillman AL, Schwartz JS.

Med Care. 1985 Nov;23(11):1283-94.

PMID:
3906295
8.

Interim funding suggested for specific kinds of new technologies prior to DRG adjustments.

Mannen T, Campbell P.

Rev Fed Am Hosp. 1985 Jul-Aug;18(4):44-7. No abstract available.

PMID:
10300252
9.

Implementing evidence-based medicine through medicare coverage decisions.

Foote SB, Town RJ.

Health Aff (Millwood). 2007 Nov-Dec;26(6):1634-42.

10.

Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.

Smith JJ, Henderson JA.

J Am Coll Radiol. 2008 Mar;5(3):189-92. doi: 10.1016/j.jacr.2007.09.005.

PMID:
18312966
11.

Payment policy and the growth of Medicare Advantage.

Zarabozo C, Harrison S.

Health Aff (Millwood). 2009 Jan-Feb;28(1):w55-67. doi: 10.1377/hlthaff.28.1.w55. Epub 2008 Nov 24.

12.

Experience with Medicare's new technology add-on payment program.

Clyde AT, Bockstedt L, Farkas JA, Jackson C.

Health Aff (Millwood). 2008 Nov-Dec;27(6):1632-41. doi: 10.1377/hlthaff.27.6.1632.

13.

Medicare as incubator for innovation in payment policy.

Janus K, Brown LD.

J Health Polit Policy Law. 2007 Apr;32(2):293-306. No abstract available.

PMID:
17463408
14.

Diffusion of new technologies: rational and irrational.

Perry S.

J Health Care Technol. 1984 Fall;1(2):73-88.

PMID:
10271139
15.

Commentary on the reimbursement paradox.

Reaven NL, Rosenbloom J.

Crit Care Med. 2009 Jul;37(7 Suppl):S285-9. doi: 10.1097/CCM.0b013e3181aa6288. Review.

PMID:
19535960
16.

Don't let cost containment stifle technological innovation.

Bessey EC.

Med Mark Media. 1986 Jan;21(1):8-10, 14, 16. No abstract available.

PMID:
10275185
17.

Diffusion of new technologies. Can Medicare payment decisions be made faster and more efficiently?

VanAntwerp M.

J Health Care Technol. 1985 Fall;2(2):97-103. No abstract available.

PMID:
10300492
18.

A happy new year for ASCs?

Zimmerman E.

Healthc Financ Manage. 2007 Dec;61(12):64-9.

PMID:
18186205
19.

The diffusion of innovations in hospitals. Some econometric considerations.

Lee RH, Waldman DM.

J Health Econ. 1985 Dec;4(4):373-80.

PMID:
10276360
20.

The need for greater price transparency in the medical device industry: an economic analysis.

Hahn RW, Klovers KB, Singer HJ.

Health Aff (Millwood). 2008 Nov-Dec;27(6):1554-9. doi: 10.1377/hlthaff.27.6.1554.

Supplemental Content

Support Center